businesspress24.com - Innoviva to Present at the Bank of America Merrill Lynch 2016 Health Care Conference on May 11
 

Innoviva to Present at the Bank of America Merrill Lynch 2016 Health Care Conference on May 11

ID: 1432476

(firmenpresse) - SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/03/16 -- Innoviva, Inc. (NASDAQ: INVA) today announced that Michael W. Aguiar, Innoviva''s President and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2016 Health Care Conference on Wednesday, May 11 at 8:40 a.m. PT, at the Wynn Las Vegas in Las Vegas.

The presentation will be webcast live and can be accessed from Innoviva''s website at or from the following link: . A replay of the presentation will be available one hour after the presentation concludes through August 8, 2016.

Innoviva, formerly known as Theravance, Inc., is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva''s portfolio is anchored by the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®, which were jointly developed by Innoviva and GSK. Under the agreement with GSK, Innoviva is eligible to receive associated royalty revenues from RELVAR®/BREO® ELLIPTA®, ANORO® ELLIPTA® and, if approved and commercialized, VI monotherapy, as well. In addition, Innoviva retains a 15 percent economic interest in future payments made by GSK for earlier-stage programs partnered with Theravance BioPharma, Inc. For more information, please visit Innoviva''s website at .

ANORO®, RELVAR®, BREO® and ELLIPTA® are trademarks of the GlaxoSmithKline group of companies.

(INVA-F)



Contact

Eric d''Esparbes
Senior Vice President and Chief Financial Officer
650-238-9640



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Marina Biotech to Acquire Late-Stage Program From Turing Pharmaceuticals
Abba Medix Group Corporate Update
Bereitgestellt von Benutzer: Marketwired
Datum: 03.05.2016 - 16:56 Uhr
Sprache: Deutsch
News-ID 1432476
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SOUTH SAN FRANCISCO, CA


Phone:

Kategorie:

Drugs


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 407 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Innoviva to Present at the Bank of America Merrill Lynch 2016 Health Care Conference on May 11
"
steht unter der journalistisch-redaktionellen Verantwortung von

Innoviva (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Innoviva



 

Who is online

All members: 10 563
Register today: 2
Register yesterday: 2
Members online: 0
Guests online: 68


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.